Literature DB >> 34432181

Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis.

Zubeyir Elmazoglu1, Handan Kayhan2, Abel Santamaría3, Edgar Rangel-López3, Pelin Kelicen Uğur4, Aslı Ceylan5, Michael Aschner6, Çimen Karasu7.   

Abstract

Neuroinflammation and oxidative stress cooperate to compromise the function of the central nervous system (CNS). Colloidal platinum nanoparticles (Pt NPs) are ideal candidates for reducing the deleterious effects of neuroinflammation since they act as free radical scavengers. Here we evaluated the effects of Pt NPs on several markers of lipopolysaccharide (LPS)-induced inflammation in cultured BV-2 microglial cells. BV-2 cells were treated with increased dilutions (1-100 ppm) of Colloidal Pt and/or LPS (1-10 µg/mL) at different exposure times. Three different protocols of exposure were used combining Pt NPs and LPS: (a) conditioning-protective effect (pre-post-treat), (b) therapeutic effect (co-treat) and (c) conditioning-therapeutic effect (pre-co-treat). After exposure to LPS for 24 h, cells were used for assessment of cell viability, reactive oxygen species (ROS) generation, lactate dehydrogenase (LDH) activity, apoptosis and caspase-3 levels, cell proliferation, mitochondrial membrane potential, inducible nitric oxide (iNOS) activity, pro-inflammatory cytokine (IL-1β, TNF-α and IL-6) levels, and phagocytic activity. Low concentrations (below or equal to 10 ppm) of Colloidal Pt prevented or ameliorated the LPS-induced increase in ROS formation, loss of mitochondrial membrane potential, induction of apoptosis, increase in LDH release, increase in pro-inflammatory cytokines and iNOS, inhibition of phagocytosis linked to microglial persistence in the M1 phase phenotype, loss of cell adhesion, differentiation and/or proliferation, as well as loss of cell viability. These protective effects were evident when cells were preconditioned with Pt NPs prior to LPS treatment. Collectively, the findings demonstrate that at low concentrations, Pt NPs can regulate the function and phenotype of BV-2 cells, activating protective mechanisms to maintain the microglial homeostasis and reduce inflammatory events triggered by the inflammatory insults induced by LPS. These preventive/protective effects on the LPS pro-inflammatory model are linked to the antioxidant properties and phagocytic activity of these NPs.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Colloidal Pt; Lipopolysaccharide; Microglial BV-2 cells; Neuroinflammation; Neuroprotection; Oxidative stress; PlatinSai®; Platinum nanoparticles

Mesh:

Substances:

Year:  2021        PMID: 34432181     DOI: 10.1007/s11064-021-03434-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  59 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

2.  GM1 induces p38 and microtubule dependent ramification of rat primary microglia in vitro.

Authors:  Ji-Young Park; Hee Young Kim; Ilo Jou; Sang Myun Park
Journal:  Brain Res       Date:  2008-10-07       Impact factor: 3.252

Review 3.  Microglia: a sensor for pathological events in the CNS.

Authors:  G W Kreutzberg
Journal:  Trends Neurosci       Date:  1996-08       Impact factor: 13.837

Review 4.  Macrophage plasticity and polarization in tissue repair and remodelling.

Authors:  Alberto Mantovani; Subhra K Biswas; Maria Rosaria Galdiero; Antonio Sica; Massimo Locati
Journal:  J Pathol       Date:  2012-11-29       Impact factor: 7.996

5.  Sex differences in microglial colonization of the developing rat brain.

Authors:  Jaclyn M Schwarz; Paige W Sholar; Staci D Bilbo
Journal:  J Neurochem       Date:  2012-02-09       Impact factor: 5.372

Review 6.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms.

Authors:  Michelle L Block; Luigi Zecca; Jau-Shyong Hong
Journal:  Nat Rev Neurosci       Date:  2007-01       Impact factor: 34.870

7.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 8.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

9.  Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures.

Authors:  Ryan J Horvath; Nancy Nutile-McMenemy; Matthew S Alkaitis; Joyce A Deleo
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

Review 10.  Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain.

Authors:  Utpal S Bhalala; Raymond C Koehler; Sujatha Kannan
Journal:  Front Pediatr       Date:  2015-01-14       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.